to top

Funding awarded to develop novel technologies for Juvenile Idiopathic Arthritis Management

Lab4Living researcher Ursula Ankeny has been awarded funding by The Children’s Hospital Charity for her project to further develop and conduct a ‘real-world’ proof-of-concept assessment of a suite of three products for children and young people with Juvenile idiopathic arthritis (JIA). The products collectively aim to improve the independence and functional ability of children with JIA. For more details about the award, follow this link:

Funding awarded to develop novel technologies for Juvenile Idiopathic Arthritis Management- NIHR CYP MedTech News, August 2021

More details about the project can be found on the JIA project page.

Categories:

Tags: